UiPath (NYSE:PATH) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

UiPath (NYSE:PATH) posted its quarterly earnings results on Thursday. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01, Briefing.com reports. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The firm had revenue of $316.00 million during the quarter, compared to analysts’ expectations of $303.69 million. During the same quarter in the prior year, the firm posted ($0.09) EPS. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. UiPath updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

UiPath Trading Down 6.0 %

PATH stock opened at $11.97 on Friday. UiPath has a 1-year low of $10.37 and a 1-year high of $27.87. The firm has a market cap of $6.86 billion, a PE ratio of -74.84 and a beta of 0.87. The business’s 50-day moving average price is $12.20 and its two-hundred day moving average price is $16.71.

Analysts Set New Price Targets

A number of research firms recently weighed in on PATH. Wells Fargo & Company upped their target price on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday. Mizuho dropped their target price on UiPath from $25.00 to $14.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Scotiabank decreased their price target on UiPath from $30.00 to $25.00 and set a “sector perform” rating on the stock in a research note on Wednesday, May 29th. TD Cowen dropped their price objective on UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a research note on Friday. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $16.00 price target on shares of UiPath in a research report on Friday. Sixteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, UiPath currently has an average rating of “Hold” and a consensus price target of $17.71.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.